Market Access Insights provides access to HTA, reimbursement, regulatory, clinical trial, and pricing information so that you can make more informed market access decisions.





Generate the evidence you need to go from research to market, overcome regulatory hurdles, or support payer approval.
Partner with IQVIA to access health economic modeling solutions to support market-specific reimbursement, market access and high-impact scientific publications.
Beyond data and insights, work with our local experts to help you manage health technology assessment bodies’ requirements around the world to shorten timeframes and reduce costs and operational burdens.
An international network that can deliver local solutions with global oversight, including expertise about the new EU HTA Regulation.
Access to the world's most comprehensive non-identified patient-level data and the ability to leverage real world evidence in health economic modeling.
Therapeutic and cross functional expertise (R&D, PMA, Epi, etc.) for scientifically rigorous and commercially relevant solutions.
Data suppliers
Healthcare professionals
Petabytes of unique data
Data feeds
Non-identified patient records
Sources of social media
Optimize your outcomes research with validated, representative, relevant results. Generate actionable insights with solutions that apply innovative data collection techniques and cross-link de-identified data to close data gaps.
Advantages include:
Partner with IQVIA to conduct best-in-class indirect treatment comparison programs
With a history of 25 years and more than 5,200 publications and presentations, our bibliography captures real world insights into patients, diseases, treatments, outcomes and costs across virtually all therapeutic areas and projects completed in more than 50 countries.
Post-COVID pricing and evidence policy changes and their implications for development and commercialization
Are usage experience and outcome benefits from person-centered therapeutic innovations appropriately valued?
Market Access Insights provides access to HTA, reimbursement, regulatory, clinical trial, and pricing information so that you can make more informed market access decisions.
Use emerging data sources and advances in evidence methods to demonstrate product value and safety.